Introduction: Most Americans with symptoms of depression and anxiety receive treatment exclusively from their primary care providers (PCPs). Existing primary care interventions typically do not occur within the initial patient interaction, rely on delivery by mental health specialists, and have lengthy training programs. This study evaluated the feasibility and acceptability of the training workshop for an ultra-brief cognitive-behavioral therapy (UB-CBT) single-session intervention for depression and anxiety symptoms that was developed to address these barriers.

Method: The 1-hr UB-CBT training workshop was piloted in 2021 with 38 providers at three adult primary care and five family medicine sites in Vermont. PCPs completed questionnaires after the training workshop. Data were collected in 2021 with a sample of participants who were primarily women (66%) and white (82%). We used a concurrent triangulation design integrating mixed-methods data.

Results: Most providers found the training highly feasible and acceptable. The majority agreed or strongly agreed that the workshop provided sufficient training for using the intervention (91%), they were satisfied with the UB-CBT intervention (92%), and the intervention seemed easy to administer (97%). Qualitative findings highlighted that providers especially liked the user-friendliness and general feasibility of the intervention, but had some concerns about time.

Discussion: We outlined several steps that will address PCPs' concerns to improve the UB-CBT training experience and intervention. Future research should examine the effectiveness of the UB-CBT intervention. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Download full-text PDF

Source
http://dx.doi.org/10.1037/fsh0000862DOI Listing

Publication Analysis

Top Keywords

primary care
16
training workshop
16
ultra-brief cognitive-behavioral
8
cognitive-behavioral therapy
8
feasibility acceptability
8
training
8
depression anxiety
8
ub-cbt training
8
ub-cbt intervention
8
intervention
7

Similar Publications

Background: Proton pump inhibitors (PPI) for gastroesophageal reflux disease (GERD) are associated with a high failure rate. Our uncontrolled feasibility study aimed determining the effect of a transcutaneous electrical stimulation system (TESS) on GERD symptoms and acid exposure time (AET).

Methods: Recruited patients with heartburn and regurgitation.

View Article and Find Full Text PDF

Introduction: The World Health Organization (WHO) recommends the use of antiretroviral drugs as post-exposure prophylaxis (PEP) for preventing HIV acquisition for occupational and non-occupational exposures. To inform the development of global WHO recommendations on PEP, we reviewed national guidelines of PEP for their recommendations.

Methods: Policies addressing PEP from 38 WHO HIV priority countries were obtained by searching governmental and non-governmental websites and consulting country and regional experts; these countries were selected based on HIV burden, new HIV acquisitions and the number of HIV-associated deaths.

View Article and Find Full Text PDF

Pseudomonal Vasculopathy of the Central Nervous System in a 2-Year-Old Female With an IRAK4-Related Immunodeficiency.

Fetal Pediatr Pathol

January 2025

Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, St. Louis, MO, USA.

, a gram-negative bacillus, has varied clinical manifestations with septicemia as the most lethal. PA infection is usually regarded as opportunistic and often nosocomial. We present a case of a "healthy" pediatric patient presenting with upper respiratory symptoms who rapidly deteriorated.

View Article and Find Full Text PDF

Aims: Although individuals with lower socio-economic position (SEP) have a higher prevalence of mental health problems than others, there is no conclusive evidence on whether mental healthcare (MHC) is provided equitably. We investigated inequalities in MHC use among adults in Stockholm County (Sweden), and whether inequalities were moderated by self-reported psychological distress.

Methods: MHC use was examined in 31,433 individuals aged 18-64 years over a 6-month follow-up period, after responding to the General Health Questionnaire-12 (GHQ-12) in 2014 or the Kessler Six (K6) in 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!